Stock Events

Stock Events

PMGC 

$5.21
71
-$0.02-0.38% Friday 19:55
+$0.00+0.04%Friday 23:31After hours

Statistics

Day High
5.21
Day Low
5.21
52W High
2,671.2
52W Low
4.97
Volume
34
Avg. Volume
-
Mkt Cap
4.22M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-1,313.22%Profit Margin
Unprofitable
2022
2023
2024
2025
590,000Revenue
-7.75MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ELAB. It's not an investment recommendation.
Tesla
5
TSLA
Rocket Lab
5
RKLB
Lucid Group
5
LCID
NVIDIA
4
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
CRISPR Therapeutics is a gene editing company that competes in the biotech space with innovative treatments, potentially overlapping with Elevai Labs' research and development in biotechnological advancements.
Editas Medicine
EDIT
Mkt Cap485.31M
Editas Medicine is involved in genome editing technology, directly competing with any of Elevai Labs' efforts in genetic research and therapy development.
Intellia Therapeutics
NTLA
Mkt Cap1.8B
Intellia Therapeutics is a leading genome editing company, which could be in direct competition with Elevai Labs if they are involved in similar genetic research or therapeutic applications.
Vertex Pharmaceuticals
VRTX
Mkt Cap137.3B
Vertex Pharmaceuticals incorporates biotechnological research for treating serious diseases, potentially competing with Elevai Labs in the biotech innovation space.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals is known for its innovative biopharmaceuticals, possibly competing with Elevai Labs in areas of drug discovery and development.
Alnylam Pharmaceuticals
ALNY
Mkt Cap31.73B
Alnylam Pharmaceuticals focuses on RNAi (RNA interference) therapeutics, competing with Elevai Labs if they explore similar genetic or molecular therapies.
Biomarin Pharmaceutical
BMRN
Mkt Cap12.52B
BioMarin Pharmaceutical develops and commercializes innovative biopharmaceuticals, potentially competing with Elevai Labs in the development of novel treatments.

About

PMGC Holdings Inc IS advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
Show more...
CEO
Graydon Bensler
Employees
34
Country
United States
ISIN
US73017P6079

Listings

XNAS
US
ELAB
BOATS
BOATS
ELAB.BOATS

0 Comments

Share your thoughts

FAQ

What is PMGC stock price today?▼
The current price of ELAB is $5.21 USD — it has decreased by -0.38% in the past 24 hours. Watch PMGC stock price performance more closely on the chart.
What is PMGC stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange PMGC stocks are traded under the ticker ELAB.
Is PMGC stock price growing?▼
ELAB stock has fallen by -1.88% compared to the previous week, the month change is a -46.84% fall, over the last year PMGC has showed a -99.52% decrease.
What is PMGC market cap?▼
Today PMGC has the market capitalization of 4.22M
What is PMGC revenue for the last year?▼
PMGC revenue for the last year amounts to 590,000 USD.
What is PMGC net income for the last year?▼
ELAB net income for the last year is -7.75M USD.
How many employees does PMGC have?▼
As of September 05, 2026, the company has 34 employees.
In which sector is PMGC located?▼
PMGC operates in the Health & Wellness sector.
When did PMGC complete a stock split?▼
The last stock split for PMGC was on August 21, 2026 with a ratio of 1:10.
Where is PMGC headquartered?▼
PMGC is headquartered in NEWPORT BEACH, United States.